After repeatedly wowing investors, Roche’s star eye med Vabysmo collected more than $4 billion in sales during its third year on the market. Still, questions continue to swirl about an evolving ...
A study has shown that Roche's diabetic macular oedema (DME) therapy Vabysmo is effective in patients who identify as African American, Black, Hispanic and Latino, plugging a gap in the data for ...
Supply for Vabysmo PFS will become available to Canadian ophthalmologists and their patients in the coming months. Roche Canada is committed to continuing to work with the provincial and ...
However, Eylea’s sales have been under pressure in the last couple of years due to competition from Roche’s RHHBY Vabysmo. The uptake of Roche’s Vabysmo has been phenomenal. Roche has ...
MISSISSAUGA, ON, Jan. 20, 2025 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that Health Canada has authorized Vabysmo® (faricimab injection) for use in a 6.0 mg ...
Hoffmann-La Roche Limited (Roche Canada) announced that Health Canada has authorized Vabysmo (faricimab injection) for use in a 6.0 mg single-use pre-filled syringe (PFS) for use in the treatment of ...
Supply for Vabysmo PFS will become available to Canadian ophthalmologists and their patients in the coming months. Roche Canada is committed to continuing to work with the provincial and territorial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback